Cargando…
Characterization of pre‐analytical sample handling effects on a panel of Alzheimer's disease–related blood‐based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group
INTRODUCTION: Pre‐analytical sample handling might affect the results of Alzheimer's disease blood‐based biomarkers. We empirically tested variations of common blood collection and handling procedures. METHODS: We created sample sets that address the effect of blood collection tube type, and of...
Autores principales: | Verberk, Inge M. W., Misdorp, Els O., Koelewijn, Jannet, Ball, Andrew J., Blennow, Kaj, Dage, Jeffrey L., Fandos, Noelia, Hansson, Oskar, Hirtz, Christophe, Janelidze, Shorena, Kang, Sungmin, Kirmess, Kristopher, Kindermans, Jana, Lee, Ryan, Meyer, Matthew R., Shan, Dandan, Shaw, Leslie M., Waligorska, Teresa, West, Tim, Zetterberg, Henrik, Edelmayer, Rebecca M., Teunissen, Charlotte E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148379/ https://www.ncbi.nlm.nih.gov/pubmed/34845818 http://dx.doi.org/10.1002/alz.12510 |
Ejemplares similares
-
Blood‐based biomarkers for Alzheimer's disease
por: Leuzy, Antoine, et al.
Publicado: (2021) -
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease
por: Hansson, Oskar, et al.
Publicado: (2022) -
Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease
por: Janelidze, Shorena, et al.
Publicado: (2015) -
Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
por: Palmqvist, Sebastian, et al.
Publicado: (2019) -
CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
por: Janelidze, Shorena, et al.
Publicado: (2018)